ROST
52
5
KMX
64
6
BSX
70
2
WEC
55
2
AON
52
2
K
57
4
SLG
66
2
ITW
62
4
THC
55
-4
KIM
76
2
ISRG
76
2
ICE
62
3
TROW
51
3
VRSK
77
4
JWN
42
2
MAS
56
5
AXP
69
3
IBM
60
6
BA
49
-3
AVGO
22
2
ROST
52
5
KMX
64
6
BSX
70
2
WEC
55
2
AON
52
2
K
57
4
SLG
66
2
ITW
62
4
THC
55
-4
KIM
76
2
ISRG
76
2
ICE
62
3
TROW
51
3
VRSK
77
4
JWN
42
2
MAS
56
5
AXP
69
3
IBM
60
6
BA
49
-3
AVGO
22
2
Financhill
Back

Utah Medical Products Vs. Perspective Therapeutics Industry Stock Comparison

Sell
24

UTMD
Utah Medical Products

Last Price:
65.30
Seasonality Move:
4.57%
Sell
30

CATX
Perspective Therapeutics

Last Price:
3.49
Seasonality Move:
34.33%
Sell
24
Utah Medical Products (UTMD) is a Sell

Is Utah Medical Products a Buy, Sell or Hold?

  • The current Utah Medical Products [UTMD] share price is $64.57. The Score for UTMD is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • UTMD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.00. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

UTMD Stock Price Chart

What is Utah Medical Products's stock price today?

  • The Utah Medical Products share price today is $64.57
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UTMD is experiencing buying pressure, which is a positive indicator for future bullish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

UTMD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 42.23 Sell
Chaikin Money Flow: 18620 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (64.01 - 66.97) Sell
Bollinger Bands (100): (64.92 - 69.18) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.83 Sell
Relative Strength Index (14 RSI): 9.64 Sell
Chaikin Money Flow: -11653674 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.08 - 12.98) Sell
Bollinger Bands (100): (10.5 - 14.68) Sell

UTMD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 65.92 Sell
20-day SMA: 65.54 Sell
50-day SMA: 65.94 Sell
200-day SMA: 68.02 Sell
8-day EMA: 65.44 Sell
20-day EMA: 65.72 Sell
50-day EMA: 66.04 Sell
200-day EMA: 69.8 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.54 Sell
20-day SMA: 10.1 Sell
50-day SMA: 11.82 Sell
200-day SMA: 12.75 Sell
8-day EMA: 7.04 Sell
20-day EMA: 9.29 Sell
50-day EMA: 11.19 Sell
200-day EMA: 11.43 Sell

Utah Medical Products Earnings Growth & UTMD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

Utah Medical Products Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):